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Abstract
The coordinated exit of intracellular pathogens from host cells is a process critical to the
success and spread of an infection. While phospholipases have been shown to play impor-
tant roles in bacteria host cell egress and virulence, their role in the release of intracellular
eukaryotic parasites is largely unknown. We examined a malaria parasite protein with phos-
pholipase activity and found it to be involved in hepatocyte egress. In hepatocytes, Plasmo-
dium parasites are surrounded by a parasitophorous vacuole membrane (PVM), which
must be disrupted before parasites are released into the blood. However, on a molecular
basis, little is known about how the PVM is ruptured. We show that Plasmodium berghei
phospholipase, PbPL, localizes to the PVM in infected hepatocytes. We provide evidence
that parasites lacking PbPL undergo completely normal liver stage development until mero-
zoites are produced but have a defect in egress from host hepatocytes. To investigate this
further, we established a live-cell imaging-based assay, which enabled us to study the tem-
poral dynamics of PVM rupture on a quantitative basis. Using this assay we could show that
PbPL-deficient parasites exhibit impaired PVM rupture, resulting in delayed parasite
egress. A wild-type phenotype could be re-established by gene complementation, demon-
strating the specificity of the PbPL deletion phenotype. In conclusion, we have identified for
the first time a Plasmodium phospholipase that is important for PVM rupture and in turn for
parasite exit from the infected hepatocyte and therefore established a key role of a parasite
phospholipase in egress.
Author Summary
Leaving their host cell is a crucial process for intracellular pathogens, allowing successful
infection of other cells and thereby spreading of infection. Plasmodium parasites infect he-
patocytes and red blood cells, and inside these cells they are contained within a vacuole
like many other intracellular pathogens. Before parasites can infect other cells, the
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surrounding parasitophorous vacuole membrane (PVM) needs to be ruptured. However,
little is known about this process on a molecular level and Plasmodium proteins mediating
lysis of the PVM during parasite egress have not so far been identified. In this study, we
characterize a Plasmodium phospholipase and show that it localizes to the PVM of para-
sites within hepatocytes. We demonstrate that parasites lacking this protein have a defect
in rupture of the PVM and thereby in host cell egress. In conclusion, our study shows for
the first time that a phospholipase plays a role in PVM disruption of an intracellular
eukaryotic parasite.
Introduction
The controlled exit of intracellular pathogens from host cells is an important step in infection
and pathogenesis. This process is important for determining an organism’s life-cycle progres-
sion and the efficiency of a secondary infection and additionally the route and timing of egress
may influence host immune responses [1]. Compared to what is known about the molecular
mechanisms pathogens use to invade host cells, the process of host cell exit is much less under-
stood. To escape from host cells, many pathogens have to disrupt two membranes, that of the
vacuole they are contained within and the plasma membrane of the host cell. Although differ-
ent molecules have been identified that play a role in the disruption of membranes, the precise
mechanisms of membrane degradation are not well understood. For bacteria and intracellular
protozoan parasites, pore-forming proteins (PFPs) have been shown to be involved in promot-
ing vacuole escape. Similarly, bacterial phospholipases have also been identified as playing key
roles in the disruption of vacuole membranes (reviewed in [1,2]).
Plasmodium parasites infect hepatocytes and red blood cells (RBCs) and inside these cells
reside in a parasitophorous vacuole (PV). The PV membrane (PVM) is formed during invasion
by invagination of the host cell plasma membrane [3] and is extensively modulated by the para-
site through the insertion of Plasmodium-specific proteins and depletion of host proteins (re-
viewed in [4]). At the end of their development, parasites disrupt the PVM during the tightly
regulated process of egress and are released, which is essential for progression of an infection.
For both blood and liver stage parasites, it has been shown that cysteine proteases play a key
role in egress. In both stages, the general cysteine protease inhibitor E64 blocks egress from the
PV and members of the Plasmodium serine repeat antigen (SERA) family are cleaved shortly
before the release of parasites [5,6,7,8]. For the blood stage, subtilisin-like protease 1 (SUB1)
and dipeptidyl peptidase 3 (DPAP3) have been identified to be part of a protease cascade re-
sulting in parasite release [6,9] and recently it could be demonstrated that PbSUB1 also plays
an important role for parasite egress at the end of liver stage development [10,11].
In addition to proteases, it has been demonstrated that perforin-like proteins and kinases
are involved in parasite egress. Plasmodium parasites express a small, conserved family of pro-
teins encoding perforin-like proteins (PPLPs) containing membrane-attack complex/perforin
domains [12]. One of these proteins, PPLP1, has membranolytic activity and localizes to the
PVM and RBC membranes of Plasmodium falciparum blood stages just before egress [13] and
gametocyte stage parasites deficient in PPLP2 were unable to escape from their host RBC
[14,15]. In addition, Plasmodium parasites deficient in either cGMP-dependent protein kinase
(PKG) or the calcium-dependent protein kinase 5 (CDPK5) exhibit defects in parasite egress
[16,17]. Furthermore, it has been shown that a liver stage-specific protein, LISP1, plays an im-
portant role in PVM disruption, but in contrast to the aforementioned proteins, LISP1 has no
defined functional domain and its molecular function is unknown [18].
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Despite this knowledge regarding the importance of proteases, kinases and perforin-like
proteins for Plasmodium egress, the precise ordering of events and cellular mechanisms gov-
erning membrane degradation/disintegration remain unknown. Whether proteases have a di-
rect role in membrane disruption by hydrolysis of membrane bound proteins or if they in turn
activate other effectors is unclear.
Intracellular bacteria, such as Listeria and Rickettsia, use phospholipases to rupture vacuolar
membranes [19,20] and it is reasonable to assume that other pathogens including Plasmodium
parasites employ similar mechanisms to be liberated at the end of their development. However,
the role of Plasmodium phospholipases in membrane disruption during egress has not been an-
alyzed so far, although several putative phospholipases have been identified in Plasmodium
based on sequence or structural similarity to phospholipases from other organisms (GeneDB.
org).
Studies using phospholipase-C (PLC) inhibitors demonstrated that PLC activity is involved
in multiple processes ranging from gametocyte development and sporozoite motility to egress
of merozoites by regulating Ca2+ release [21,22,23]. Attempts to disrupt the gene encoding
Plasmodium berghei PI-PLC (phosphoinositide-specific phospholipase C) have been unsuc-
cessful, indicating an essential role for blood stage development [24]. Another protein on the
surface of P. berghei sporozoites has been shown to exhibit phospholipase and membrane lytic
activity in vitro [25]. This protein, P. berghei phospholipase (PbPL, PBANKA_112810), con-
tains a predicted signal sequence and a carboxyl terminus that is 32% identical to the human
lecithin:cholesterol acyltransferase, a secreted phospholipase [25]. Sporozoites deficient in
PbPL expression have a reduced capacity to cross epithelial cell layers, indicating a role for
PbPL in damaging host cell membranes.
In this study, we analyze the localization and role of PbPL during liver stage development.
We show that PbPL is located at the PVM of liver stage parasites and that mutants deficient in
PbPL exhibit a delayed egress as a result of impaired rupture of the PVM. Together, this is the
first report of a protein with phospholipase activity that is involved in PVM disruption by a
protozoan parasite.
Results
PbPL is expressed throughout liver stage development and localizes to
the PVM
PbPL was shown to be expressed on the surface of sporozoites and to have an important role
during transmigration of sporozoites through cells [25]. However, it was not known whether
PbPL is also expressed during liver stage development. We therefore first analyzed its tran-
scription by RT-PCR, which showed mRNA expression of PbPL throughout liver stage devel-
opment (Fig. 1A). To determine protein expression and PbPL localization, we generated a
mouse antiserum against a hydrophilic fragment of PbPL (amino acid 195 to 312). Performing
immunofluorescence assays (IFA) with the anti-PbPL antiserum revealed that PbPL colocalizes
with the PVM resident protein exported protein I (ExpI, PBANKA_092670) in infected hepa-
tocytes 30 and 54 hours post-infection (hpi). At 30 hpi, PbPL was also observed in vesicular
structures within the parasite cytoplasm, which may be newly synthesized PbPL located in se-
cretory vesicles being transported to the PVM. No signal was observed in liver stages of PbPL-
knockout (KO) parasites (see below), confirming the specificity of the antiserum for PbPL
(Fig. 1B). We further confirmed the localization by generating parasites expressing a
PbPL-GFP fusion protein under the liver stage specific lisp2 (PBANKA_100300) promoter
[26], in which PbPL-GFP also localized to the PVM (Fig. 1C). These observations, that PbPL is
A Plasmodium Phospholipase Is Involved in PVM Rupture
PLOS Pathogens | DOI:10.1371/journal.ppat.1004760 March 18, 2015 3 / 25
A Plasmodium Phospholipase Is Involved in PVM Rupture
PLOS Pathogens | DOI:10.1371/journal.ppat.1004760 March 18, 2015 4 / 25
expressed by parasites in infected hepatocytes and localizes to the PVM, may indicate that
PbPL also plays a role in parasite development after sporozoite invasion.
Generation of PbPL-KO parasites and PbPL complementation
To assess the role of PbPL in liver stage development, we sought to analyze a PbPL-KO parasite
line. Unfortunately, the existing PbPL deletion mutant [25] shows insufficient fluorescence to
allow liver stage development analysis using our assays. For this reason, we generated a new
PbPL-KO parasite line by targeted deletion of the pbpl gene by double crossover homologous
recombination (Fig. 2A). A gene-specific plasmoGEM vector [27,28] was transfected into
blood stage schizonts of a marker-free P. berghei reporter line (mCherryhsp70) that expresses
mCherry at high levels under the control of the hsp70 (PBANKA_071190) regulatory se-
quences throughout the life cycle, making it particularly useful for fluorescence-based assays
(S1 Fig.). Parasites of the mCherryhsp70 line are hereafter referred to as wild-type (WT) para-
sites. Successful deletion of PbPL was confirmed in two clonal KO parasite lines (KO1 and
KO2) by diagnostic PCR (Fig. 2B).
To validate that any potential mutant phenotype is the result of the absence of PbPL, we re-
introduced the pbpl gene into KO parasites, taking advantage of the fact that the vector used
for generation of the PbPL-KO contains a fusion of the positive drug selectable marker hdhfr
(human dihydrofolate reductase) and the negative marker yfcu (yeast cytosine deaminase and
uridyl phosphoribosyl transferase) under the control of the P. berghei eef1α promoter. To allow
complementation, we first removed the selectable marker by treating KO2 parasites with 5-Fluor-
ocytosine (5-FC), selecting for marker-free PbPL-KO parasites that had undergone homologous
recombination between the two 3’dhfr untranslated regions present in the targeting vector flank-
ing the hdhfr::yfcu cassette (Fig. 2A). Successful removal of the selectable marker in a clonal KO
parasite line was confirmed by diagnostic PCR (Fig. 2C). In a next step, we complemented these
marker-free PbPL-KO parasites by transfection of a plasmid, in which expression of a V5-tagged
PbPL is under the control of the endogenous pbpl promoter (Fig. 3A). We confirmed the correct
complementation in three clonal lines (CMP1–3) by diagnostic PCR (Fig. 3B). In addition, PbPL
expression during liver stage infection in these complemented lines was demonstrated by IFA
using either our anti-PbPL antiserum or an anti-V5 antibody (Fig. 3C).
PbPL-KO sporozoites have a defect in egress from oocysts
We first checked mosquito development of PbPL-KO parasites and found that they did not dif-
fer fromWT and complemented parasites with respect to: (i) the kinetics of male gamete egress
after in vitro gametocyte activation (S2A Fig.), (ii) formation of male exflagellation centers
after in vitro activation (S2B Fig.), (iii) production of oocysts (S2C Fig.) and (iv) the production
of sporozoites inside oocysts (midgut sporozoites, S2D Fig.). However, we detected fewer
PbPL-KO sporozoites in both the mosquito hemolymph (S2E Fig.) and salivary glands (S2F
Fig.) compared to both WT and complemented parasites. The reduced number of hemolymph
and salivary gland sporozoites despite the production of normal numbers of sporozoites within
Fig 1. PbPL is expressed throughout liver stage development and localizes to the PVM. A) PbPL mRNA expression profile in blood stages (BS) and in
liver stages at 24, 48, 54 and 60 hours post-infection (hpi). Transcripts were detected by RT-PCR, using primers specific for PbPL and P. berghei
glyceraldehyde-3-phosphate dehydrogenase (GAPDH, PBANKA_132640) as a control. B) Endogenous PbPL localizes to the PVM. An antiserum against
His-PbPL195–312 was raised in a mouse and used in IFA of wild-type (WT) and PbPL-knockout (KO2) liver stage parasites constitutively expressing cytosolic
mCherry. Parasites were fixed at 30 and 54 hpi and additionally stained with an antiserum against the PVMmarker protein ExpI. C) GFP-tagging of PbPL
confirms PVM localization. PbPL was expressed as a GFP-fusion protein in P. berghei liver stage parasites additionally constitutively expressing cytosolic
mCherry, which were fixed at 54 hpi and analyzed by IFA. PbPL (green), ExpI (purple), mCherry (red). The merged channels additionally contain DAPI-
stained nuclei (blue). Scale bars = 10 μm.
doi:10.1371/journal.ppat.1004760.g001
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oocysts indicates that PbPL-KO sporozoites have a defect in their egress from oocysts. A func-
tion of PbPL during sporozoite formation was not completely unexpected, since a previous
study has shown that the pbpl promoter is active in oocysts [29].
Fig 2. Generation and genotype analyses of PbPL-knockout parasite lines. A) Schematic representation of knockout (KO) strategy and marker
recycling. Two clonal PbPL-KO parasite lines were generated by transfection of wild-type (WT) blood stage parasites with a plasmoGEM vector containing a
fusion of the positive drug selectable marker hdhfr (human dihydrofolate reductase) and the negative marker yfcu (yeast cytosine deaminase and uridyl
phosphoribosyl transferase) under the control of the P. berghei eef1α promoter (grey box) targeting the PbPL coding sequence by double crossover
homologous recombination followed by pyrimethamine selection. The selection marker was removed by negative selection with 5-Fluorocytosine (5-FC),
whereby marker-free PbPL-KO parasites (KO-MF) were selected that had undergone homologous recombination between the two 3’dhfr untranslated
regions (black boxes) present in the targeting vector flanking the hdhfr::yfcu cassette. Locations of primers used for PCR analysis are shown. B) Diagnostic
PCR to confirm PbPL-KO clones. Primer 1 and 2 are expected to give a product of 398 bp in case of WT parasites, while primer 3 and 4 are expected to yield
a product of 2058 bp for KO parasites. C) Diagnostic PCR to confirm successful removal of selectable marker. Primers 5 and 6 bind in the yfcu gene and are
therefore expected to only give a product of 909 bp in case of selectable marker containing KO parasites. Primers 7 and 2 are expected to give a product of
2568 bp in case of WT, a product of 3782 bp for KO and a product of 1001 bp for KO-MF parasites. All primer sequences are listed in S1 Table.
doi:10.1371/journal.ppat.1004760.g002
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Fig 3. Generation and confirmation of complemented PbPL-knockout parasites. A) Schematic representation of the plasmid pL0017.1.2-
5’FR-PbPL-V5 used to transfect marker-free PbPL-knockout (KO-MF) parasites, thereby generating complemented PbPL-KO (CMP) parasites. The PbPL
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PbPL-KO parasites take longer to appear in the blood after sporozoite
infection
When we infected C57BL/6 mice intravenously with 1,000 sporozoites of WT, KO or comple-
mented parasites, the first blood stage parasites were detected in all mice 3 days after sporozoite
injection. However, parasitemia for PbPL-KO parasites was significantly lower in comparison
to both WT and complemented parasites on day 4 and subsequent days, as determined by
FACS analysis (Fig. 4). These observations indicate either a reduced sporozoite infectivity, a de-
fect during liver stage development or egress, or a reduced growth rate of blood stage parasites.
To exclude that the lower parasitemia of PbPL-KO parasites after sporozoite infection is the re-
sult of a reduced growth rate of blood stages, we calculated the blood stage multiplication rate
of PbPL-KO parasites from the increase in parasitemia after sporozoite infection (S3A Fig.). In
addition, we analyzed blood stage growth in mice after intravenous injection of 1,000 WT,
PbPL-KO or complemented blood stage parasites (S3B Fig.). The results of these analyses
showed that the blood stage growth of PbPL-KO parasites was comparable to that of WT and
complemented parasites, indicating that PbPL does not play a critical role during blood stage
development. To analyze whether the reduced parasitemia is the result of a reduced infection
coding sequence and the endogenous promoter region (1067 bp upstream of the start codon) were amplified from wild-type (WT) parasite gDNA by PCR and
cloned in frame with a c-terminal V5-tag into a pL0017-derived plasmid. This vector integrates into the c- or the d-ssu-rRNA locus via single crossover
recombination and conveys resistance to pyrimethamine. B) Diagnostic PCR of complemented parasite lines. Successful integration of the transfected
plasmid into either of two possible loci in the P. berghei genome was tested by PCR. Locations of primers used for PCR analysis are shown. For each locus,
one primer pair (1 and 4, 2 and 4, respectively) yields a PCR product of 3 kb if no integration has taken place. In case of successful integration, the primers
are too far apart (>14 kb) to result in a complete PCR product under the chosen conditions. To further confirm integration, additional primer pairs (1 and 3, 2
and 3) were used, which only generate a PCR product of 3 kb if the plasmid has integrated. C) Complemented parasites express PbPL-V5 under the
endogenous promoter. HepG2 cells were infected with complemented PbPL-KO sporozoites (CMP2) constitutively expressing cytosolic mCherry (red), fixed
at 54 hpi and analyzed by IFA using an antiserum against PbPL (green, upper panel) or a monoclonal antibody against the V5-tag (green, lower panel) in
combination with an antiserum against the PVMmarker protein ExpI (purple). The merged channels additionally contain DAPI-stained nuclei (blue). Scale
bars = 10 μm. IFAs are representative for the CMP1 and CMP3 parasite lines, which showed similar PbPL- and V5-stainings. All primer sequences are listed
in S1 Table.
doi:10.1371/journal.ppat.1004760.g003
Fig 4. PbPL-knockout parasites take longer to appear in the blood after sporozoite infection.C57BL/6 mice were injected intravenously with 1,000
wild-type (WT), PbPL-knockout (KO2) or complemented PbPL-KO (CMP2) sporozoites and subsequent blood stage parasitemia was measured by FACS
analysis. A) Blood stage parasitemia at day 4. B) Development of parasitemia between day 3 and 6 post-infection. Shown are means +/− SD of 6–7 infected
mice per group. For statistical analysis of parasitemia at day 4, a one-way analysis of variance (ANOVA) followed by a Holm-Sidak multiple comparison test
was performed (** p< 0.01, n.s. = not significant). See also S3 Fig.
doi:10.1371/journal.ppat.1004760.g004
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of liver cells by sporozoites, we quantified the liver load of mice infected with the same number
of WT, PbPL-KO or complemented sporozoites 38 hpi by real-time PCR. In agreement with
previous findings [25], we were not able to detect a difference between the parasite lines (S3C
Fig.), indicating a normal infectivity of PbPL-KO sporozoites.
In conclusion, the reduced parasitemia of PbPL-KO parasites after sporozoite infection in
combination with comparable liver loads and the absence of an obvious blood stage phenotype
indicates that PbPL-KO parasites either take longer to emerge from the liver or that fewer in-
fectious merozoites are released.
PbPL-KO parasites undergo normal liver stage development but show
impaired merozoite release
To better characterize the PbPL-KO liver stage phenotype, we next analyzed in detail the intra-
hepatic development of PbPL-KO parasites in vitro. To again exclude differences in sporozoite
infectivity, we infected HepG2 cells with the same number of WT, KO and complemented spo-
rozoites and counted infected hepatocytes at 48 hpi. KO sporozoites showed a similar infectivi-
ty to HepG2 cells in comparison to WT and complemented sporozoites (Fig. 5A), further
supporting our in vivo analyses.
To investigate whether PbPL plays a role during the growth of Plasmodium liver stages, we
measured the size of intrahepatic parasites in vitro at 48 hpi. No significant differences in size
were observed between WT, KO and complemented parasites, suggesting that PbPL is not in-
volved in liver stage development prior to this stage (Figs. 5B and S4A).
We subsequently investigated a potential role of PbPL during the final stages of liver stage
schizogony, merozoite formation and egress from host hepatocytes. First, we showed by IFA
that expression and localization of the merozoite surface protein 1 (MSP1, PBANKA_083100)
and the PVMmarker Exp1 in intrahepatic PbPL-KO parasites was the same as in WT parasites
(S4B Fig.).
Next, we counted the number of detached cells produced at the end of intrahepatic develop-
ment, as a marker for the final phase of liver stage development in vitro [5]. Cells detach upon
formation of merozoites and rupture of the PVM, followed by the release of merozoites into
the hepatocyte cytoplasm, which typically occurs between 55 and 60 hpi [5]. We observed that
PbPL-KO parasites produced approximately 60% fewer detached cells compared to WT para-
sites (Figs. 5C and S4C). Furthermore, a significant proportion of detached cells in the KO pop-
ulation showed an aberrant morphology; merozoites were not released into the hepatocyte
cytoplasm but remained clustered together (Fig. 5D). In complemented parasites, the WT phe-
notype of detached cells was completely rescued (Fig. 5C, D).
The reduced detachment in the case of mutant parasites could result from fewer parasites
that successfully form merozoites or from a defect in PVM disruption. In the latter case, an in-
crease in attached hepatocytes containing merozoites may be predicted because daughter cells
would be produced normally but due to a defect in PVM disruption, cell detachment would
not occur. To distinguish between these possibilities, we quantified attached hepatocytes con-
taining schizont, cytomere and merozoite stages at 54 and 65 hpi. At 54 hpi, before PVM rup-
ture, no significant difference in the number of hepatocytes containing merozoites existed
between WT, PbPL-KO and complemented parasites, indicating normal merozoite formation
up to this time point (Fig. 6). In contrast, at 65 hpi, a time point where the PVM is disrupted in
normally developed WT parasites, a significantly higher number of attached hepatocytes con-
taining merozoites was seen for PbPL-KO parasites compared to WT parasites, indicating im-
paired merozoite release and a potential defect in PVM disruption (Fig. 6).
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Fig 5. PbPL does not affect liver stage growth but plays a role in detached cell formation A) PbPL-knockout (KO2) sporozoites have a similar infectivity
as wild-type (WT), and complemented PbPL-KO (CMP2) sporozoites. For determination of sporozoite infectivity, HepG2 cells were infected with 10,000WT,
KO2 or CMP2 sporozoites and the average number of infected host cells per well was quantified 48 hpi in triplicate. Numbers of infected host cells were not
statistically different from each other (one-way ANOVA, p = 0.6892). B) PbPL-knockout parasites grow normally in size. HepG2 cells were infected with WT,
KO2 and complemented PbPL-KO (CMP1–3) sporozoites. 48 hpi, parasite size (area) was determined by density slicing using ImageJ. For each parasite
line, the average size of 50–100 parasites was determined in each of three separate experiments. Parasites did not show a significant difference in size (one-
way ANOVA, p = 0.6567). C) PbPL-KO parasites produce fewer detached cells (DCs). DCs in the supernatant were counted at 65 hpi in triplicate and were
normalized to the number of infected cells at 48 hpi. D) Detached cells from PbPL-KO parasites show an abnormal morphology. DCs were harvested at 65
hpi and the percentage of cells with an abnormal morphology was determined. DCs with abnormal morphology were defined by merozoites still being
clustered in the PV in contrast to merozoites freely distributed in the host cell in DCs with normal morphology. A representative image of DCs with normal and
abnormal morphology is shown. Scale bars = 10 μm. For all experiments means +/− SD of three to four independent experiments are shown. For statistical
analysis a one-way ANOVA followed by a Holm-Sidak multiple comparison test was performed (** p< 0.01, *** p< 0.001, n.s. = not significant). See also
S4 Fig.
doi:10.1371/journal.ppat.1004760.g005
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We were able to rescue the WT phenotype by complementation, although complemented
parasites showed a small but statistically significant increase in merozoite release compared to
WT parasites in this assay. This difference in merozoite release could be the result of slightly in-
creased PbPL-expression levels in complemented parasites compared to WT parasites. This
may be explained by the process of complementation, where the DNA construct encoding the
pbpl gene was introduced into the PbPL-KO genome by single-crossover recombination, possi-
bly resulting in multiple insertions of the DNA construct. This increase in pbpl gene copy num-
ber could then lead to higher PbPL expression levels compared to that in WT parasites.
Further, even the expression level of a single introduced PbPL expression construct might re-
sult in differences in PbPL expression, since we used only 1067 bp upstream of the pbpl start
codon as a promoter region in the complementation vector, and consequently may not have
captured the entire pbpl promoter, resulting in altered expression levels.
PbPL-KO parasites exhibit a defect in PVM disruption
To further analyze impaired merozoite release in PbPL-KO parasites and a potential role of
PbPL in PVM disruption, we infected GFP-expressing HepG2 cells with WT and PbPL-KO
parasites and analyzed their intrahepatic development from the cytomere stage to cell detach-
ment by live-cell time-lapse microscopy. An intact PVM is impermeable to host cell-derived
GFP, whereas PVM rupture leads to a rapid GFP influx into the PV [30]. Analysis of GFP
Fig 6. PbPL is involved in merozoite release.HepG2 cells were infected with wild-type (WT), PbPL-knockout (KO2) and complemented PbPL-KO (CMP2)
sporozoites. The percentage of attached hepatocytes containing schizont (S), cytomere (C) and merozoite (M) stage parasites was determined at 54 and 65
hpi. Schizont stages are either negative for the merozoite surface protein MSP1 or display an MSP1 staining only at the parasite plasmamembrane without
invaginations. Cytomere stages are defined by their MSP1-positive parasite plasmamembrane with clear invaginations, while in merozoite-containing
hepatocytes, individual merozoites are surrounded by MSP1 staining. Representative MSP1 staining of each parasite stage is shown at the top. For each
time point, 50–100 parasites were analyzed. Scale bars = 10 μm. Shown are means +/− SD of three independent experiments. For statistical analysis a one-
way ANOVA followed by a Holm-Sidak multiple comparison test was performed (** p< 0.01, *** p< 0.001).
doi:10.1371/journal.ppat.1004760.g006
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influx by live-cell time-lapse microscopy therefore allows the determination of the percentage
of merozoite-forming parasites with a disrupted PVM and quantification of the speed of PVM
disintegration. Nearly all WT parasites that developed to the merozoite stage were able to dis-
rupt the PVM, with an average time of 70 minutes (Fig. 7, S1 Movie). In contrast, PbPL-KO
parasites that developed to the merozoite stage either did not rupture the PVM at all or this
process was significantly delayed (Fig. 7, S2 Movie). Importantly, the WT phenotype was
completely rescued in complemented parasites (Fig. 7, S3 Movie). In conclusion this experi-
ment shows that in the absence of PbPL, PVM rupture is compromised, confirming the results
of the detached cell (Figs. 5C, and S4C) and the stage quantification assays (Fig. 6) and provid-
ing a perfect explanation for the observed delay in development of blood stage parasitemia
after sporozoite infection (Fig. 4).
Discussion
In intracellular bacterial pathogens, phospholipases have been shown to play a key role in host
cell exit [1,2], whereas the role of this class of proteins in intracellular protozoans, including
Plasmodium parasites, was unknown. In this study we have identified PbPL, a Plasmodium
protein with phospholipase activity, as having a key role in disruption of the liver stage PVM.
This is the first time that a Plasmodium phospholipase has been implicated in egress from a
host cell.
Bhanot et al. have previously found that PbPL has phospholipase activity, is expressed on
the surface of sporozoites and that it has a role in damaging host cell membranes, thereby as-
sisting in the migration of sporozoites to the hepatocyte [25]. Together with our observations,
demonstrating that PbPL-KO parasites are impaired in their egress from oocysts and from he-
patocytes, this protein appears to have important functions in three life cycle stages prior to the
blood stage of infection:
(i) in oocysts, where it plays a role in egress of sporozoites, (ii) in sporozoites, where it plays
a role in migration through host tissue mediating hepatocyte invasion and (iii) in liver stages,
where it is involved in PVM rupture mediating efficient merozoite release.
When Bhanot et al. injected a large number of PbPL-deficient sporozoites intravenously,
they did not observe a prolonged prepatent period by blood smear. However, they observed a
delayed prepatency when a much lower number of sporozoites were transferred by mosquito
bite [25]. Our own observations principally confirm the finding of Bhanot et al., as the first
blood stage parasites were detected in all mice 3 days after sporozoite injection. However, de-
termination of parasitemia by the more sensitive method of FACS analysis revealed a signifi-
cantly lower parasitemia for KO parasites, suggesting that PbPL also contributes to parasite
egress in vivo.
In support of the function PbPL has in PVM disruption, the protein is located at the PVM,
already being detectable there at 30 hpi, some time before the actual rupture of the PVM oc-
curs. This may suggest that in the developing liver stage parasite, PbPL remains in an inactive
state and its activation results in PVM rupture. A coordinated cascade of events involving ki-
nases and resulting in the activation of proteases has been defined as being important for para-
site release (reviewed in [31]) and this signaling and protease activation cascade may also
include PbPL activation, for example by phosphorylation or proteolytic cleavage. As kinases
and proteases are not likely membranolytic, an attractive scenario is that their activation con-
verges on lipases like PbPL. In line with this hypothesis, proteolytic activation of phospholi-
pases was already shown for a Listeria PLC [32] and for several secreted phospholipases of
Staphylococcus (reviewed in [33]). Candidates for a potential proteolytic activation of PbPL
could be the proteases of the SERA family that, like PbPL, also localize to the PVM in infected
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Fig 7. PbPLmediates disruption of the PVM.HepG2 cells expressing GFP (green) were infected with mCherry-expressing wild-type (WT), PbPL-knockout
(KO2) and complemented PbPL-KO (CMP2) sporozoites (red). The percentage of merozoite-forming parasites that ruptured the PVM and the time difference
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hepatocytes [7,8]. However, so far proteolytic cleavage of substrates has not been directly
shown for any of the P. falciparum or P. berghei SERAs. Direct and indirect evidence that
SERAs with a cysteine residue in the active center are indeed real proteases came from two re-
cent studies: One study showed that the putative active site cysteine of P. falciparum SERA6 is
essential and that the P. berghei orthologue of SERA6 could be converted by SUB1-mediated
cleavage to an active cysteine protease showing autoprocessing activity [34]. The other study
revealed that the exchange of the serine residue in the active center of P. falciparum SERA5 to a
cysteine allows peptide binding and cleavage [35]. These observations, the localization of differ-
ent SERAs in the PV or even in the PVM and the fact that expression of the majority of P. ber-
ghei SERAs is restricted to the last few hours before merozoite egress from infected hepatocytes
[7,8], suggest a possible role in initiation of PVM rupture by, for example, processing and acti-
vation of PbPL or other membranolytic enzymes.
While our study demonstrates that PbPL is involved in disruption of the PVM, our observa-
tions also show that a proportion of PbPL-KO parasites are able to disrupt the PVM inside the
infected hepatocyte in the absence of PbPL. This indicates that PVM disruption can be brought
about by other parasite molecules, albeit less efficiently, or can occur by non-specific (possibly
mechanical) processes. The ability of the parasite to utilize multiple exit strategies is further
supported by the absence of any obvious blood stage phenotype in PbPL-deficient parasites. In-
terestingly, the absence of other Plasmodium proteins shown to be involved in egress, such as
LISP1 [18] and the perforin-like molecule PPLP2 [14,15], also did not result in an absolute
‘non-egress’ phenotype. Host cell egress is such a critical process for intracellular parasites that
presumably several different effector proteins and mechanisms exist, which may have partially
overlapping, redundant or even synergistic functions. Therefore, the absence of just one effec-
tor molecule, such as PbPL, may only lead to a partial defect in egress. An example of this func-
tional redundancy has been described in Listeria [19], where separate deletion of two
phospholipases had only moderate effects on the infectivity to mice (2–20 fold reduction),
whereas the deletion of both phospholipases together severely impaired infectivity (500 fold re-
duction). In line with this, the apparently moderate phenotype resulting from the deletion of
PbPL enables the generation of double mutants in the future, providing an opportunity to iden-
tify other proteins working in conjunction with PbPL, and thereby may help us to more
completely understand the process and the hierarchy of events that facilitate parasite exit from
the host cell.
Our current working hypothesis is that PbPL works together with other phospholipases or
pore-forming proteins (PFPs), like the already mentioned Plasmodium perforin-like proteins
[12]. In general, the combination of membranolytic enzymes might be specific for each egress
event in the life cycle and for different Plasmodium species, depending on the composition of
between successful formation of merozoites and PVM rupture was measured by quantitative live-cell imaging. The influx of GFP into the PV was used as a
measure of PVM rupture. Imaging was started around 55 hpi and lasted for 12 hours. Representative images for WT (A) and PbPL-KO (B) parasites are
shown. The upper images show the time point of successful merozoite formation, at which individual merozoites were visible and all larger yet undivided
parts of the parasite cytoplasm, typical of the cytomere stage, had disappeared. The lower images show the time point of PVM rupture (GFP influx) in a host
cell infected with a WT parasite and the end point of imaging of a host cell infected with a PbPL-KO parasite, in which the PVM did not rupture (the course of
events are better visible in the corresponding S1–S3 Movies). Scale bars = 10 μm. C) Time between formation of merozoites and PVM rupture. Each line
represents the time difference between successful merozoite formation (beginning of line) and PVM rupture (end of line), as illustrated in A and B, and
corresponds to one analyzed parasite. Continuous lines indicate parasites that did not rupture the PVM at all, which were not considered for determination of
the average PVM rupture time in E. D) Percentage of merozoite-forming parasites that ruptured the PVM. The percentage of PVM rupture was determined in
3 (KO2, CMP2) or 6 (WT) imaging sessions, in which the number of parasites that successfully developed to merozoites within the first 6 hours of imaging
was set to 100% in each experiment. Based on these, the percentage of parasites that successfully ruptured the PVMwas calculated. E) Elapsed time from
merozoite formation to PVM rupture. In D and E, means +/− SD are shown. Data were acquired in and are representative of 3 (KO2, CMP2) or 6 (WT)
imaging experiments, in which a total of 61WT, 43 KO2 and 37 CMP2 parasites were analyzed. For statistical analysis a one-way ANOVA followed by a
Holm-Sidak multiple comparison test was performed (**** p< 0.0001, n.s. = not significant). See also S1–S3 Movies.
doi:10.1371/journal.ppat.1004760.g007
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the PVM that the parasite has to rupture and the exit strategy employed. It makes sense, for ex-
ample, that the lysis of the RBC PVM differs from that of infected hepatocytes, as in RBCs the
same enzymes probably also rupture the host plasma membrane within seconds, whereas the
plasma membrane of hepatocytes needs to be preserved for several hours until merosomes are
formed and reach the blood stream [5].
We consider PFPs as promising candidates to be involved in PbPL-mediated PVM disrup-
tion, as they were shown to play a key role in host cell egress of intracellular bacteria, for which
it has been suggested that PFPs and phospholipases may act in concert [36]. Although the de-
tailed molecular basis of this is unknown, PFPs might make certain membrane leaflets accessi-
ble for the action of lipases. In Plasmodium the PFPs of the perforin-like protein family consist
of five conserved proteins all containing a membrane-attack complex/perforin domain [12].
Members of this family have been shown to be important for ookinete and sporozoite host cell
traversal [37,38,39] and have also been implicated in host cell egress by asexual and sexual
blood stage parasites [13,14,15]. However, studies on the role of perforin-like proteins at the
end of liver stage development are so far missing and it can only be speculated that these pro-
teins contribute to parasite egress from infected hepatocytes. Interestingly, key roles of PFPs in
egress have also been established for several other protozoan parasites, including Trypanosoma
cruzii, Leishmania and Toxoplasma gondii [40,41,42], but a putative function of phospholi-
pases in exit of these parasites from their host cells has not been investigated so far.
Taken together, our study identifies PbPL as the first Plasmodium phospholipase that is im-
portant for PVM disruption and in turn for parasite exit from the infected hepatocyte and
therefore establishes a key role of a parasite phospholipase in egress. We strongly believe that
PbPL, because its function is significant but not lethal, offers the unique opportunity to learn
more about parasite egress strategies. We now aim to identify the specific combination of
membranolytic enzymes needed for membrane rupture and to understand the mechanisms by
which these enzymes act together, as they might represent a new class of parasite-specific tar-
gets for intervention.
Materials and Methods
Ethics statement
All experiments performed at the University of Bern were conducted in strict accordance with
the guidelines of the Swiss Tierschutzgesetz (TSchG; Animal Rights Laws) and approved by the
ethical committee of the University of Bern (Permit Number: BE109/13). All experiments per-
formed at the LUMC were approved by the Animal Experiments Committee of the Leiden
University Medical Center (Permit Number: DEC 12042). The Dutch Experiments on Animals
Act was established under European guidelines (EU directive no. 86/609/EEC regarding the
Protection of Animals used for Experimental and Other Scientific Purposes).
Experimental animals
Mice used in the experiments were between 6 and 10 weeks of age and were from Harlan Labo-
ratories, Charles River or bred in the central animal facility of the University of Bern. Mosquito
feeds were performed on mice anaesthetized with Ketavet/Domitor and all efforts were made
to minimize suffering.
For the generation of mCherryhsp70 parasites, Swiss mice were used. The in vivo phenotype
of PbPL-KO parasites was analyzed in C57BL/6 mice, while for all other experiments Balb/c
mice were used.
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Mosquito infection
Infections of mice were initiated by intraperitoneal injection of P. berghei blood stabilates.
When these mice had a parasitemia of 4%, 150 μl or 40 μl of infected blood were injected intra-
peritoneally or intravenously, respectively, into mice that had received an intraperitoneal injec-
tion of 200 μl phenylhydrazine (6 mg/ml in PBS) 2–3 days before. At day 3 or 4 after infection,
mice with a parasitemia of at least 7% were anaesthetized for 1 hour to allow feeding of 150 fe-
male Anopheles stephensimosquitoes. The next day, unfed mosquitoes were removed. Mosqui-
toes were kept at 20.5°C with 80% humidity and for infection experiments, sporozoites were
isolated from infected salivary glands 16–27 days after the infective blood meal.
Culture and infection of HepG2 cells
HepG2 cells (obtained from the European cell culture collection) were cultured as described
before [30]. For infection, either 3 or 5 x 104 cells were seeded in 24-well plates with or without
coverslips. The next day, P. berghei sporozoites were isolated from the salivary glands of in-
fected A. stephensimosquitoes and added to HepG2 cells in culture medium additionally con-
taining 2.5 μg/ml amphotericin B (PAA Laboratories). After an incubation period of 2 hours,
the sporozoite-containing medium was removed and fresh infection medium was added. Sub-
sequently, medium was changed once per day.
Gene expression analysis
Total RNA was isolated from 0.05% saponin-treated P. berghei infected red blood cells and in-
fected HepG2 cells 24, 48, 54 and 60 hpi using the NucleoSpin RNA II kit (Macherey-Nagel).
Random-primed cDNA synthesis was performed using GoScript reverse transcriptase (Pro-
mega) and the resulting cDNA was then used as a template in PCR reactions using GoTaq
Flexi DNA polymerase (Promega) with the primer pairs PbPL-expression-fw/PbPL-expres-
sion-rev and GAPDH-expression-fw/GAPDH-expression-rev. All primer sequences are listed
in S1 Table.
Cloning of DNA constructs
All PCR reactions were performed using Phusion DNA polymerase (NEB). PCR products were
routinely cloned into pJET1.2 (Fermentas) and confirmed by sequencing.
For generation of the PbPL bacterial expression vector parallel-1-His-PbPL195–312, the cod-
ing sequence corresponding to a hydrophilic fragment of PbPL ranging from amino acid 195
to 312 was amplified from blood stage cDNA using primer pair PbPL-antiserum-fw/PbPL-an-
tiserum-rev, which was then cloned into the parallel-1-His vector [43] using BamHI and XhoI
restriction sites.
The PbPL-GFP expression vector pL0043LSPbPL-GFPCmCherry was generated by first am-
plifying the PbPL coding sequence from blood stage cDNA using primer pair PbPL-GFP-fw/
PbPL-GFP-rev, which was subsequently digested with BglII and ligated into the BamHI di-
gested liver stage-specific expression vector pGFP103464 [26] in frame with GFP. From there the
LSPbPL-GFP expression cassette was cloned via EcoRV and KpnI into the pL0043 vector [44],
which targets the P. berghei 230p locus by double crossover homologous recombination. Final-
ly, a constitutive mCherry expression cassette was integrated via KpnI, which had been ampli-
fied before from the pCmCherry plasmid [45] using primers mCherry-fw and mCherry-rev.
For generation of the PbPL-complementation vector pL0017.1.2-5’FR-PbPL-V5, the vector
pL0017.1.2 was generated at first. For this, the GFP coding sequence was excised from
pGFP103464 [26] using BamHI and XbaI digestion and then replaced by a double-stranded
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DNA oligonucleotide (obtained by annealing the single-stranded DNA oligonucleotides 50-
GATCCGCGGCCGCCCTAGGAGGTAAGCCTATCCCTAACCCTCTCCTCGGTCTC-
GATTCTACGTAGT-30 and 50-CTAGACTACGTAGAATCGAGACCGAGGAGAGGGT-
TAGGGATAGGCTTACCTCCTAGGGCGGCCGCG-30), bearing the coding sequence for the
V5-tag (underlined) as well as a NotI restriction site. In a second step, the PbPL coding se-
quence and 1067 bp of the upstream region (endogenous promoter) were amplified in two
parts from P. berghei genomic DNA. The upstream region and the N-terminus of PbPL were
amplified with primer PbPL-5FR-fw (containing a SacII restriction site) and primer PbPL-
nterm-rev. The C-terminal part of PbPL was amplified with primer PbPL-cterm-fw and primer
PbPL-cterm-rev (containing a NotI restriction site). Next, a SnaBI restriction site present with-
in the PbPL coding sequence was used to join both parts together in a 3-way-ligation, for
which a SacII/NotI digested intermediate vector was used. The resulting vector was linearized
with SacII and subsequently blunted, followed by NotI digestion. This resulted in release of the
joined endogenous promoter region and the PbPL coding sequence, which could be then ligat-
ed in frame with the V5 tag into the EcoRV/NotI-digested pL0017.1.2 vector, thereby replacing
the lisp2 promoter and generating pL0017.1.2-5’FR-PbPL-V5. All primer sequences are listed
in S1 Table.
Generation of PbPL-specific antiserum
His-PbPL195–312 was expressed from plasmid parallel-1-His-PbPL195–312 in the BL21 (DE3)
[pAPlacIQ] E. coli strain and purified using Ni-NTA agarose (Qiagen). For generation of the
His-PbPL antiserum, 50 μg of the purified protein were mixed with one volume of Freund’s ad-
juvant complete (Sigma) and subcutaneously injected into a Balb/c mouse. After two weeks,
the mouse was boosted with the same amount of protein mixed with Freund’s adjuvant incom-
plete (Sigma), followed by a second boost two weeks later. The immunized mouse was sacri-
ficed, blood was collected and antiserum was obtained after centrifugation of the coagulated
blood.
Expression of PbPL-GFP in P. berghei parasites
The linearized plasmid pL0043LSPbPL-GFPCmCherry was transfected into blood stage schiz-
onts of the GIMOANKA parasite line [44] as described previously [46] and selection of trans-
fected parasites was carried out by adding 5-FC (Abcam) to the drinking water of infected mice
[47].
Immunofluorescence assays
3 x 104 HepG2 cells were seeded on coverslips in 24-well plates and infected the following day
with P. berghei sporozoites. At different time points post-infection, cells were fixed with 4%
PFA in PBS for 20 minutes at room temperature, followed by permeabilization with ice-cold
methanol. Unspecific binding sites were blocked by incubation in 10% FCS in PBS, followed by
incubation with primary antibodies (rabbit anti-GFP (Invitrogen), rat anti-V5 (Invitrogen),
mouse anti-PbPL, chicken anti-Exp1 and rat anti-MSP1 (both generated at the Bernhard-
Nocht Institute, Hamburg, Germany)) and subsequently with fluorescently labeled secondary
antibodies (anti-rabbit AlexaFluor488 (Invitrogen), anti-rat AlexaFluor488 (Invitrogen), anti-
chicken Cy5 (Dianova), anti-mouse AlexaFluor488 (Invitrogen)) diluted in 10% FCS in PBS.
DNA was visualized by staining with 1 μg/ml DAPI (Sigma). Labeled cells were mounted on
microscope slides with Dako Fluorescent Mounting Medium (Dako) and analyzed by confocal
point scanning microscopy using a Zeiss LSM5 Duo microscope and a Zeiss Plan-Apochromat
63×/1.4 oil objective. Image processing was performed using ImageJ.
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Generation of selectable marker-free mCherryhsp70 parasites
The construct pL1694 was used to generate the reporter line mCherryhsp70 that expresses
mCherry under control of the hsp70 regulatory sequences. This construct was used to target
the GIMOANKA mother line using the ‘gene insertion/marker out’ (GIMO transfection) proce-
dure [44]. To create pL1694, we modified the existing construct pL1628 [44]; this is a Pb230p
GIMO targeting construct that contains a gene encoding mCherry where expression is driven
by the P. berghei eef1α promoter and transcription is terminated by a P. berghei dhfr 3’ UTR re-
gion. We removed both the eef1α promoter and 3’ dhfr UTR regions from pL1628 and replaced
them with the promoter region and 3’ UTR (transcription terminator) sequences of P. berghei
hsp70 (PBANKA_071190). The hsp70 regulatory regions were amplified from P. berghei
ANKA genomic DNA using primers Hsp70-Promoter-fw/Hsp70-Promoter-rev for the pro-
moter and primers Hsp70-3'UTR-fw/ Hsp70-3'UTR-rev for the 3’UTR. These promoter and
3’UTR elements were cloned into pL1628 vector using the Asp718/BamHI and SpeI/Asp718 re-
strictions sites respectively. This construct was linearized by digestion with KspI before trans-
fection. The linearized DNA construct was introduced into GIMOANKA parasites using
standard methods of GIMO-transfection [44]. Transfected parasites were selected in mice by
applying negative selection by providing 5-FC in the drinking water of mice [47]. Negative se-
lection results in selection of parasites where the hdhfr::yfcu selectable marker in the 230p locus
is replaced by the mCherry reporter-cassette. Selected transgenic parasites (mCherryhsp70) were
cloned by limiting dilution. Correct integration of the constructs into the genome of mCher-
ryhsp70 parasites was analyzed by diagnostic PCR on parasite gDNA. All primer sequences are
listed in S1 Table.
Generation of PbPL-KO parasites and PbPL complementation
PbPL-KO parasites were generated by transfection of the plasmoGEM vector PbGEM-099883
[27,28] into mCherryhsp70 parasites as described before [46], targeting the PbPL coding se-
quence by double crossover homologous recombination, and were selected by pyrimethamine
(Sigma). For generation of marker-free KO parasites, the selectable marker was removed by
negative selection with 5-FC in the drinking water of infected mice as described previously
[47]. Subsequently, complemented parasites were generated by transfection of the linearized
pL0017.1.2-5’FR-PbPL-V5 vector into marker-free KO parasites, leading to expression of
PbPL-V5 under its endogenous promoter from the c- or d-ssu-rRNA locus. Parasite genomic
DNA (gDNA) was isolated from 0.05% saponin-treated infected red blood cells using the
Nucleospin Blood QuickPure kit (Macherey-Nagel) and all genetic modifications of parasites
were confirmed by diagnostic PCR using GoTaq Flexi DNA polymerase. All primer sequences
are listed in S1 Table. Clonal parasite lines were either generated by detached cell injection [48]
or by limiting dilution.
Analysis of mosquito stage development
Exflagellation of male gametocytes was analyzed using standard in vitro gametocyte activation
assays basically as described previously [49]. In brief, 2 μl of tail blood were added to 8 μl of
ookinete medium (RPMI1640 containing 25 mMHEPES, 20% FCS, 100 μM xanthurenic acid
[pH 7.4]) and the mixture was placed under a Vaseline-coated coverslip. By light microscopy
(100x objective) we counted the number of unemerged but activated male gametocytes (de-
fined as activated male gametocytes with moving flagella inside the erythrocyte) and of
emerged activated male gametocytes (with extracellular male gametes) in four 2 minute inter-
vals starting at 8 minutes post-activation. 20 minutes post-activation, the characteristic exfla-
gellation centers were counted in 20 fields of view using a light microscope (40x objective).
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9 days after the infective blood meal, midguts of 15–23 mosquitoes were dissected into PBS
and the pooled midguts were fixed in 4% paraformaldehyde (PFA) in PBS for 20 minutes at
room temperature. The midguts were then washed with PBS and stored in PBS at 4°C in the
dark. The next day, fixed midguts were mounted on glass slides containing a small amount of
Dako Fluorescent Mounting Medium and imaged using a fluorescence microscope with a 5x
objective. The average number of oocysts per midgut was then determined using an ImageJ-
based counting macro [50].
On day 18 and 26 after the infective blood meal, mosquito midguts and salivary glands were
harvested for determination of sporozoite numbers. 10 mosquitoes were dissected, organs
pooled and homogenized, and released sporozoites were counted using a hemocytometer. For
determination of hemolymph sporozoite numbers, hemolymph from 10 mosquitoes was col-
lected on day 18 after the infective blood meal by perfusion of the thorax and abdomen with
50 μl of PBS and sporozoites were counted using a hemocytometer.
In vivo analysis of PbPL-KO parasites
1,000 WT, KO or complemented sporozoites were injected intravenously into 6–7 C57BL/6
mice per group. Subsequently, blood stage parasitemia was determined between day 3 and 6
post-infection by FACS analysis using a FACSCalibur flow cytometer (BD Biosciences) and the
mCherry fluorescence of parasites.
For determination of blood stage growth in mice, 1,000 infected red blood cells (containing
mixed blood stages) of WT, KO or complemented parasites were injected intravenously into
4–5 C57BL/6 mice per group and subsequent parasitemia was determined between day 3 and 6
post-infection by FACS analysis.
For determination of liver loads, 4–5 C57BL/6 mice per group were injected intravenously
with 10,000 WT, KO or complemented sporozoites. After 38 hours, whole livers were removed
and homogenized on ice in 5 ml of denaturing solution (4 M guanidine thiocyanate, 25 mM so-
dium citrate [pH 7.0], 0.5% N-lauroylsarcosine, 0.7% β-mercaptoethanol) using a Polytron ho-
mogenizer (Kinematica). Total RNA was isolated from 100 μl of liver homogenate using 900 μl
of TRIzol (Ambion). Random-primed cDNA synthesis was performed using 2 μg of total RNA
and GoScript reverse transcriptase. Levels of parasite 18S ribosomal RNA and mouse hypoxan-
thine guanine phosphoribosyltransferase (HPRT) cDNAs obtained from the reaction were
quantified by real-time PCR using previously described primers [10]: Pb18S-fw and Pb18S-rev
for P. berghei 18S ribosomal RNA and MmHPRT-fw and MmHPRT-rev for theMus musculus
housekeeping gene hprt. To quantify gene expression, MESA GREEN qPCR MasterMix Plus
(Eurogentec) was used according to the manufacturer's instructions. Reactions were performed
in triplicate in an ABI Prism 7000 sequence Detection System (Applied Biosystems) with 1 μl
of cDNA in a total volume of 25 μl and the following reaction conditions: 1 step of 2 min at
50°C, 1 step of 5 min at 95°C, 40 cycles of 15 sec at 95°C and 1 min at 60°C. Relative expression
levels were calculated using the ΔΔCt method [51]. All primer sequences are listed in S1 Table.
Determination of sporozoite infectivity in vitro
5 x 104 HepG2 cells per well were seeded in 24-well plates and infected the next day with
10,000 WT, KO and complemented sporozoites. After 48 hpi, the average number of infected
host cells per well was quantified in triplicate.
Parasite size measurement and detached cell analysis
5 x 104 HepG2 cells per well were seeded in 24-well plates and infected the next day with WT,
KO and complemented sporozoites. 48 hpi, parasite size (area) was determined by density
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slicing using ImageJ and infected cells were counted. At 65 hpi, the number of detached cells
(DCs) in the supernatant was counted in triplicate. The percentage of DC formation was then
calculated by dividing the number of DCs in the supernatant by the number of infected cells at
48 hpi. For quantification of DC morphology, DCs were harvested at 65 hpi and DCs with nor-
mal (merozoites freely distributed in host cell cytoplasm) and abnormal morphology (merozo-
ites still being clustered) were counted.
Stage quantification assay
3 x 104 HepG2 cells per well were seeded in 24-well plates on coverslips and infected the next
day with WT, KO and complemented sporozoites. They were fixed at 54 and 65 hpi and
stained for IFA with an anti-MSP1 antiserum as already described. Subsequently, attached he-
patocytes containing schizont, cytomere and merozoite stage parasites were counted based on
parasite plasma membrane morphology.
PVM rupture assay
2 × 106 HepG2 cells were transfected with 4 μg pEGFP-N3 plasmid (Clontech) using an
Amaxa nucleofector (Lonza) as described previously [30] and subsequently seeded into
4-chamber glass bottom dishes (In Vitro Scientific). The following day, two wells of GFP-ex-
pressing cells were infected with mCherry-expressing WT and the other two either with KO or
complemented sporozoites. The percentage of merozoite-forming parasites that rupture the
PVM, as defined by influx of GFP into the PV, as well as the time between successful formation
of merozoites and PVM rupture was subsequently analyzed by live-cell time-lapse imaging.
For this, a Zeiss LSM5 Duo microscope with a Zeiss Plan-Apochromat 63×/1.4 oil objective
was used in the LIVE mode (confocal line scanning). Development of parasites shortly before
or in the cytomere stage was followed for 12 hours starting between 54 and 56 hpi using the
Zeiss LSMMultitime-Macro and an image was acquired every 10 minutes. During imaging,
cells were kept in a CO2 incubator at 37°C. Only parasites that developed to the merozoite
stage within the first 6 hours of imaging and displayed completely normal development (e.g.
absence of merofusosomes [52]) were used for further analysis. Image processing was per-
formed using ImageJ.
Statistical analyses
Statistical analyses were performed using GraphPad Prism (GraphPad Software). For compari-
sons between groups, a one-way analysis of variance (ANOVA) followed by a Holm-Sidak
multiple comparison test was perfomed. P values of< 0.05 were considered significant.
Accession numbers
P. berghei phospholipase (PBANKA_112810), P. berghei glyceraldehyde-3-phosphate dehydro-
genase (PBANKA_132640), P. berghei LISP2 (PBANKA_100300), P. berghei exported protein
1 (PBANKA_092670), P. berghei heat shock protein 70 (PBANKA_071190), P. berghei 18S ri-
bosomal RNA (berg07_18S), P. bergheimerozoite surface protein 1 (PBANKA_083100),M.
musculus hypoxanthine guanine phosphoribosyltransferase (NM_013556.2).
Supporting Information
S1 Fig. Generation of the marker-free P. berghei ANKA reporter line mCherryhsp70, ex-
pressing mCherry under the control of the hsp70 regulatory sequences. A) Schematic repre-
sentation showing the introduction of the mCherry-reporter cassette (pL1694) into the
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GIMOANKA parasite line. Construct pL1694 contains the hsp70 promoter (5’hsp70)-mCherry-
3’hsp70 (terminator) cassette. The construct integrates into the modified P. berghei 230p locus
containing the hdhfr::yfcu selectable marker cassette by double crossover homologous recombi-
nation at the target regions (grey boxes). Negative selection with 5-Fluorocytosine selects for
the transgenic parasite line mCherryhsp70 that has the mCherry-reporter cassette introduced
into the 230p locus and the hdhfr::yfcumarker removed. Location of primers used for PCR
analysis are shown. B) Diagnostic PCR-analysis confirms the correct integration of construct
pL1694 into the P. berghei genome. Diagnostic PCR-analysis shows the absence of the hdhfr::
yfcumarker and the correct integration of the mCherry expression cassette into the mCher-
ryhsp70 genome. In case of successful integration, primers 1 and 2 are expected to yield a PCR
product of 951 bp and primers 3 and 4 a product of 1056 bp. Primers 5 and 6 amplify mCherry
and give a product of 718 bp, while 7 and 8 bind within the selectable marker resulting in a
product of 1108 bp. C) mCherry expression in midgut (MG) oocysts and salivary gland (SG)
sporozoites of mosquitoes 20 days after infection with mCherryhsp70. D) Oocyst of mCher-
ryhsp70 parasites 12 days after infection. E) Individual salivary gland sporozoites of mCher-
ryhsp70 parasites 18 days after infection. Scale bars = 10 μm. All primer sequences are listed in
S1 Table.
(TIFF)
S2 Fig. Mosquito stage development of PbPL-knockout parasites. A, B) Male gametocytes of
PbPL-knockout (KO) parasites emerge normally in time and numbers. The proportion of
exflagellating male gametocytes of wild-type (WT), PbPL-KO (KO2) and complemented
PbPL-KO (CMP2) that had emerged from their host erythrocyte was scored by light microsco-
py at different times after the induction of gametogenesis in vitro (A). 20 minutes after induc-
tion, the average number of exflagellation centers per field of view was determined using a 40x
objective (B). C) PbPL-KO parasites produce normal numbers of oocysts. 9 days after the infec-
tive blood meal, midguts were removed and for each parasite line the average number of oo-
cysts per midgut was determined from 15–23 mosquitoes per experiment. D, E, F) PbPL-KO
sporozoites have a defect in egress from oocysts. 18 and 26 days after the infective blood meal,
the average number of sporozoites in the mosquito midgut (D) or salivary glands (F) was quan-
tified. In addition, the average number of sporozoites in the hemolymph was determined 18
days after the infective blood meal (E). For each mosquito feed, 10 mosquitoes were dissected
and sporozoites were counted. For all experiments means +/− SD of 4–8 independent mosquito
feed experiments are shown. For statistical analysis a one-way ANOVA followed by a Holm-
Sidak multiple comparison test was performed. All statistically significant differences are indi-
cated by asterisks ( p< 0.05,  p< 0.01,  p< 0.001,  p< 0.0001).
(TIFF)
S3 Fig. PbPL-knockout parasites show normal blood stage development and liver infection
levels in vivo (related to Fig. 4). A) The blood stage multiplication rate of PbPL-knockout
(KO2) parasites does not differ from wild-type (WT) and complemented PbPL-KO (CMP2)
parasites. The blood stage multiplication rate was calculated by dividing the parasitemia deter-
mined by FACS analysis (Fig. 4) of each individual mouse at day 5 and day 6 after sporozoite
injection by the parasitemia the respective mouse had one day before. Shown are means +/−
SD of 6–7 mice per group. B) Blood stage growth curve of WT, KO2 and CMP2 parasites.
1,000 mixed blood stage parasites were injected intravenously into C57BL/6 mice and subse-
quent parasitemia was measured by FACS analysis. Shown are means +/− SD of 8–9 mice per
group obtained in two independent experiments. C) PbPL-KO parasites show similar liver
loads in comparison to WT and CMP2 parasites. C57BL/6 mice were injected intravenously
with 10,000 WT, KO2 or CMP2 sporozoites. After 38 hours, total RNA was isolated from
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whole infected livers and levels of 18S ribosomal parasite RNA (Pb18S) and mouse hypoxan-
thine guanine phosphoribosyltransferase (MmHPRT) mRNA were quantified by real-time
PCR. Relative amounts of parasite 18S ribosomal RNA were normalized against the expres-
sion levels of mouse HPRT and infection levels of WT parasites were set to 100%. Shown are
means +/− SD of 4–5 mice per group. There was no statistically significant difference in liver
infection levels between the groups (one-way ANOVA, p = 0.5567).
(TIFF)
S4 Fig. PbPL does not affect liver stage growth but plays a role in detached cell formation
(related to Fig. 5). A) Both clonal PbPL-knockout (KO) parasite lines develop normally in
size. HepG2 cells were infected with wild-type (WT) and PbPL-KO (KO1 and KO2) sporozo-
ites. 48 hpi, parasite size (area) was determined by density slicing using ImageJ. For each para-
site line, the average size of 50–100 parasites was determined in each experiment. B) PbPL-KO
parasites show normal MSP1 and ExpI expression and localization. HepG2 cells were infected
with WT and KO2 sporozoites, fixed at 60 hpi and analyzed by IFA using an antiserum against
the plasma membrane marker protein MSP1 (green) and the PVMmarker protein ExpI (pur-
ple). The merged channels additionally contain DAPI-stained nuclei (blue). Scale
bars = 10 μm. C) Both clonal PbPL-KO parasite lines produce fewer detached cells (DCs). DCs
in the supernatant were counted at 65 hpi in triplicate and were normalized to the number of
infected cells at 48 hpi. For all experiments means +/− SD of three independent experiments
are shown. For statistical analysis, a one-way ANOVA followed by a Holm-Sidak multiple
comparison test was performed ( p< 0.01, n.s. = not significant). Parasite sizes in (A) did
not differ statistically significantly from each other (one-way ANOVA, p = 0.9531).
(TIFF)
S1 Movie. Successful PVM rupture of a wild-type parasite (related to Fig. 7).HepG2 cells
expressing GFP (green) were infected with mCherry-expressing wild-type sporozoites (red).
Parasite development was followed by confocal live-cell time-lapse microscopy and imaging
was started around 55 hpi. 4 frames per second and 10 minutes time interval between each
frame. Scale bar = 10 μm.
(AVI)
S2 Movie. Unsuccessful PVM rupture of a PbPL-knockout parasite (related to Fig. 7).
HepG2 cells expressing GFP (green) were infected with mCherry-expressing PbPL-knockout
(KO2) sporozoites (red). Parasite development was followed by confocal live-cell time-lapse
microscopy and imaging was started around 55 hpi. 4 frames per second and 10 minutes time
interval between each frame. Scale bar = 10 μm.
(AVI)
S3 Movie. Successful PVM rupture of a complemented PbPL-knockout parasite (related to
Fig. 7).HepG2 cells expressing GFP (green) were infected with mCherry-expressing comple-
mented PbPL-knockout (CMP2) sporozoites (red). Parasite development was followed by con-
focal live-cell time-lapse microscopy and imaging was started around 55 hpi. 4 frames per
second and 10 minutes time interval between each frame. Scale bar = 10 μm.
(AVI)
S1 Table. Primers used in this study. Restriction sites are underlined if present.
(PDF)
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